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Introduction
Cardiovascular diseases are the leading cause of death globally, 
killing 17.5 million people per year and 80% of deaths from 
these diseases occur in low- and middle-income countries.1,2 
Evidence suggests that the main drivers of the global cardiovas-
cular disease epidemic are urbanization and industrialization, 
which lead to an increase in sedentary lifestyles, unhealthy 
dietary patterns, tobacco consumption and increased al-
cohol consumption.3 Hypertension is a leading risk factor 
for cardiovascular diseases, and its prevalence is increasing 
worldwide – from 25% in 2000 to a projected 40% in 2025.4 
The rising burden of hypertension in low- and middle-income 
countries is amplified by the public’s low levels of awareness, 
treatment and control of this condition, particularly among 
slum residents, who typically constitute a large portion of 
neglected urban populations in such settings.5,6 Studies in 
slum populations suggest that when people are made aware 
of having hypertension they do tend to seek care.5,6 However, 
the level of adherence to treatment for hypertension remains 
low for several reasons, including, but not limited to, the 
high costs of treatment and to patients’ perceptions of a low 
risk of cardiovascular diseases and belief in a one-time cure 
for disease rather than to lifelong preventive treatment and 
monitoring.7–12
In response to the rising burden of cardiovascular disease 
risk factors in slum populations in Kenya,5,6 a community-
based intervention was developed and implemented in the 
capital city, Nairobi. This intervention, known as SCALE UP 
(the sustainable model for cardiovascular health by adjusting 
lifestyle and treatment with economic perspective in settings 
of urban poverty), has been described in detail elsewhere.13 The 
intervention had multiple components with the overall aim of 
reducing cardiovascular diseases risk through awareness cam-
paigns, improvements in access to screening and standardized 
clinical management of hypertension. The aim of this paper 
is to share experiences of implementing a comprehensive in-
tervention for primary prevention of hypertension in a slum 
setting and to examine the processes, outcomes and costs of the 
intervention. The lessons learnt from this paper will be useful 
to policy-makers and other stakeholders looking to implement 
similar interventions in highly resource-constrained settings. 
Methods
Context
Korogocho slum, located in Nairobi, is home to about 35 000 
people resident across seven villages. Within this slum, two 
primary health-care centres were invited to participate: a 
private nonprofit facility and a community-owned facility. 
The intervention team set up cardiovascular diseases’ clinics 
at the facilities, provided basic screening equipment (such as 
blood pressure monitors), and trained a pair of nurses and 
clinical officers in each clinic to manage patients found to have 
hypertension, using a standardized treatment guideline devel-
oped by the study team in line with international practice.14 
Although most patients made out-of-pocket payments for ser-
vices received, the clinics offered services at highly subsidized 
prices, which were possible through donor funding. It was not 
Objective To describe the processes, outcomes and costs of implementing a multi-component, community-based intervention for 
hypertension among adults aged > 35 years in a large slum in Nairobi, Kenya.
Methods The intervention in 2012–2013 was based on four components: awareness-raising; improved access to screening; standardized 
clinical management of hypertension; and long-term retention in care. Using multiple sources of data, including administrative records 
and surveys, we described the inputs and outputs of each intervention activity and estimated the outcomes of each component and the 
impact of the intervention. We also estimated the costs associated with implementation, using a top-down costing approach.
Findings The intervention reached 60% of the target population (4049/6780 people), at a cost of 17 United States dollars (US$) per person 
screened and provided access to treatment for 68% (660/976) of people referred, at a cost of US$ 123 per person with hypertension who 
attended the clinic. Of the 660 people who attended the clinic, 27% (178) were retained in care, at a cost of US$ 194 per person retained; 
and of those patients, 33% (58/178) achieved blood pressure control. The total intervention cost per patient with blood pressure controlled 
was US$ 3205.
Conclusion With moderate implementation costs, it was possible to achieve hypertension awareness and treatment levels comparable 
to those in high-income settings. However, retention in care and blood pressure control were challenges in this slum setting. For patients, 
the costs and lack of time or forgetfulness were barriers to retention in care.
a African Population and Health Research Center, PO Box 10787-00100, Nairobi, Kenya.
b Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands.
c Department of Public Health, University of Amsterdam, Amsterdam, Netherlands.
Correspondence to Samuel Oji Oti (email: dr.otisamuel@gmail.com).
(Submitted: 7 April 2015 – Revised version received: 21 December 2015 – Accepted: 4 February 2016 – Published online: 26 April 2016 )
Bull World Health Organ 2016;94:501–509| doi: http://dx.doi.org/10.2471/BLT.15.156513502
Research
Community-based hypertension intervention in Kenya Samuel Oji Oti et al.
practical in this setting to implement an 
intervention for all cardiovascular risk 
factors and therefore treatment focused 
on blood pressure screening and pre-
scription of anti-hypertensive medica-
tion: hydrochlorothiazide, nifedipin or 
enalapril. If indicated, patients who also 
had diabetes were placed on metformin.
Study design
The intervention itself was part of a qua-
si-experimental study. For this analysis 
we aimed to measure the outcome and 
impact of each stage of the interven-
tion in terms of hypertension control. 
The intervention study was approved 
by the Kenya Medical Research Insti-
tute’s national ethics review committee 
(NON-SSC protocol no. 339; current 
controlled trials no. ISRCTN84424579). 
All participants gave written informed 
consent to participate in the interven-
tion both at the household screening 
and at the clinics.
Intervention
The intervention was developed based 
on a modelling exercise, described in 
more detail elsewhere.13,15 The interven-
tion was implemented for 18 months 
from August 2012 and had four com-
ponents: (i) raising awareness about 
cardiovascular diseases; (ii) improving 
access to screening; (iii) facilitating ac-
cess to treatment; and (iv) promoting 
long-term retention in care.
A total of 50 community health 
workers were recruited and trained 
to conduct door-to-door household 
visits to raise awareness about the bur-
den of cardiovascular diseases in the 
community and provide information 
about opportunities for screening, to 
conduct the screening and to provide 
brief counselling among the eligible 
population. The community health 
workers were trained for seven days at 
the implementing institution’s offices, 
with teaching facilitated by the project’s 
senior researchers in a classroom setting 
and including practice sessions. Health 
workers each received US$ 6 per day for 
transportation reimbursement.
Eligible people were all adults aged 
35 years or older resident in Korogocho 
slum area who were listed in the data-
base of the Nairobi urban health and 
demographic surveillance system16,17 
and who consented to participate. 
Anthropometric and clinical measure-
ments were taken at participants’ homes, 
including height, weight, waist and 
hip circumference, blood pressure and 
blood glucose (early morning, dried 
blood-spot testing). Community sensi-
tization about the household visits was 
conducted via local radio campaigns, 
community meetings and religious 
gatherings.
All persons with elevated blood 
pressure (≥ 140 mmHg systolic and/or 
≥ 90 mmHg diastolic)18 were referred 
by the community health worker to 
either of the two participating clinics. 
As an incentive for patients to seek 
care, community health workers gave 
each referred person a paper voucher 
that entitled him or her to receive a free 
1-month supply of medication – valued 
at about United States dollars (US$) 1.8 
– on their first clinic visit. All subse-
quent monthly medication prescribed 
at the clinic, however, was to be paid 
for by the patients. The consultation 
and laboratory tests were provided free 
of charge at these clinics, as usual in 
public primary health-care facilities in 
Kenya. To motivate them to follow-up 
each patient, community health workers 
received an incentive of US$ 3.0 per ap-
propriately referred patient who visited 
the health facility.
To promote retention in care, 
patients receiving treatment were or-
ganized into support groups by village. 
Each support group received an incen-
tive – a group reduction in the price of 
medication by one-third (approximately 
US$ 0.6) – if they collectively achieved 
80% or more attendance to follow-
up visits for a consecutive period of 
six months. Financial incentives were 
also offered to community health work-
ers to organize the support groups: 
US$ 1.8 per support group participant 
attending the clinics for at least six con-
secutive months as scheduled. Finally, 
we sent monthly mobile phone short 
message service (SMS) reminders to 
patients reminding them of scheduled 
clinic appointments.
Data collection and analysis
Data sources
The main sources of data were adminis-
trative records, activity reports, minutes 
of meetings and other relevant records. 
However, we supplemented these data 
with data sourced from population- and 
clinic-level surveys conducted at base-
line and at the end of the intervention 
period.19 The population-level survey 
was conducted with randomly sampled 
participants in the study community at 
baseline (August to December 2012) and 
endline (February to April 2014). The 
clinic survey involved structured inter-
views with patients attending the clinics 
only. Data for the cost analysis were col-
lected from financial records and time 
sheets and interviews with staff.
Processes and outcomes
To describe the processes we first listed 
the activities involved in the interven-
tion and the inputs needed to implement 
each activity: for example, provision of 
facilities (input) required for training 
of community health workers (activ-
ity). We then described the result of 
each activity: for example, the number 
of community health workers trained 
(output).
To evaluate the outcomes of the 
components of the intervention we de-
termined the number of people partici-
pating at each stage of the intervention 
and calculated the following measures: 
the proportion of the target population 
who were screened and referred to the 
clinic for treatment (awareness-raising 
and screening); the proportion of people 
with high blood pressure referred who 
attended the clinic for treatment (access 
to treatment); and the proportion of 
people who attended for treatment and 
made six or more clinic visits within a 
12-month period (retention in care). We 
sought to identify possible explanations 
for the outcomes observed in each stage 
of the continuum of care. For screening 
and awareness we used field reports to 
document the reasons why not every 
prioritized adult was reached by the 
intervention. For treatment-seeking and 
retention in care, we conducted semi-
structured interviews with a random 
sub-sample of referred patients who 
defaulted from scheduled visits or never 
attended the clinics.
Impact
To evaluate the overall impact of the 
intervention we collected data from 
anonymized routine medical records 
from the two clinics and calculated the 
levels of blood pressure control achieved 
among patients during the intervention. 
The main impact measure was the per-
centage of all patients retained in care 
(defined as patients with six or more 
clinic visits within a 12-month period) 
whose blood pressure was controlled to 
below 140/90 mmHg. We also calcu-
lated the percentage change in the mean 
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systolic and diastolic blood pressures of 
these patients between their first and 
sixth clinic visits.
Costs
The costs of the intervention were esti-
mated from a provider perspective and 
expressed in US$, based on the aver-
age conversion rate in 2013 of Kenyan 
shillings 85 to US$ 1. We included all 
service and above-service level costs for 
each itemized activity per intervention 
component for the 18-month duration 
of the intervention. We excluded evalu-
ation and research-related activities as 
they are not a part of service delivery. 
We used a top-down costing approach 
by allocating costs to each component 
of the intervention, then to activities 
by input type (Box 1). This was done 
through a review of financial records 
and time sheets and interviews with 
staff. Part of the management staff costs 
were first allocated out proportionally 
to the time spent on other projects. This 
was ascertained through interviews. 
The intervention staff costs were then 
allocated to implementation activities 
based on the relative duration of re-
search and implementation activities.
For all costs, we first allocated 
those costs that could be clearly tracked 
to a particular component. For the 
remaining shared costs, we allocated 
them across components based on the 
level of effort in hours dedicated to 
the activities in each component. We 
accounted for additional costs such as 
security escorts for our staff due to the 
field conditions. We report economic 
costs including items for which there 
were no financial transactions, for ex-
ample rental of clinic space (these were 
valued using market prices). Capital 
costs were converted to an annual rate 
using a discount rate of 3%.
The costs for all inputs by item-
ized activities within each interven-
tion component were then totalled 
to determine the total amount spent 
on that component. We then divided 
the total cost per component by the 
quantifiable unit of outcome per 
component, resulting in the cost per 
unit of outcome per intervention com-
ponent. Finally, we totalled the cost 
of all components and divided that 
by the number of people with blood 
pressure under control to obtain the 
cost per unit of health gain (patient 
with blood pressure controlled and 
retained in care).
Results
Processes and outcomes
Table 1 shows the details of all the activi-
ties and inputs and the resultant outputs 
for each component of the intervention.
Fig. 1 summarizes the outcomes 
of each stage of the intervention. Com-
munity health workers successfully 
screened and counselled 4049 out of 
6780 (60%) of the target population. The 
principal reasons for exclusion from the 
study were because the person refused to 
participate in the study (164; 2%), was 
believed to be resident in the slum but 
could not be reached (1161/6780; 17%), 
was no longer resident in the slum (281; 
4%) or had died (26; < 1%). Other rea-
sons accounted for 68 (1%) of drop-outs. 
A further 1031 people were not reached 
during the screening campaign but were 
traced by community health workers 
during the intervention period and 
given a complementary blood pressure 
check. However, we did not collect any 
data from these people nor did we follow 
them up at the clinic. Out of the 4049 
people screened, 976 (24%) people with 
raised blood pressure were identified 
and referred; 358 (9%) were known to 
have hypertension and 618 (15%) were 
newly diagnosed.
Out of the 976 persons referred to 
the clinics, 845 (87%) attended the car-
diovascular diseases’ clinic at least once. 
Of these, 185 were found to have normal 
blood pressure levels after confirmatory 
measurement by the nurses. Therefore 
660 patients out of 976 referred (68%) 
started on treatment with a prescrip-
tion from the clinic. Out of 131 patients 
who were referred to a clinic but did 
not attend, 61 answered the follow-up 
interviews conducted at their homes. 
The leading reported reasons for non-
attendance were lack of time (17 pa-
tients; 28%), cost of treatment (14; 23%) 
and forgot clinic appointment (9; 15%).
By the end of the intervention 
period, a total of 4519 SMS messages 
had been sent to all patients, and seven 
support groups had been formed with a 
total of 371 persons attending the meet-
ings at least once. The average number 
of support group meetings attended 
by each person was 3.5 over the entire 
intervention period.
A total of 178 out of 660 patients 
(27%) attending the clinics were re-
tained in care. Out of the 482 patients 
not retained in care, the community 
health workers followed up 127 at their 
homes; the remainder could not be 
reached after up to three revisits. The 
main reasons for not being retained 
in care included cost of treatment (45 
patients; 35%), lack of time (26; 21%) 
and forgot clinic appointment (22; 17%).
Impact
Out of 178 patients retained in care, 58 
(33%) had their blood pressure con-
trolled by the sixth visit. This amounts 
to 9% of all 660 patients recruited into 
the clinics (Fig. 1).
The mean systolic blood pressure 
of those retained in care and with com-
plete data (n = 177) was 161.6 mmHg at 
Box 1. Costs considered in each input category of the 18-month community-based 
intervention for hypertension management in Kenya, 2012–2013
Personnel input:
Salaries of all categories of staff and consultants
Commodities and supplies input:
Costs of drugs, tests, consumables and all training and communication materials
Training input:
Costs of space, travel, food and accommodation for participants, excluding staff costs
Capital cost input:
Costs of equipment, furniture, buildings (tents, floors) and labour to set up
Building operating and maintenance input:
Costs of communication, security, cleaning and repairs
Transport input:
Mileage allowance for supervision visits
Intervention activities input:
All payments for incentives to community health workers and patients, short message service 
reminders, community mobilization and adherence support
Indirect expenses input:
Reported overhead expenses
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the first visit and this was reduced by 
19.8 mmHg (95% confidence interval, 
CI: 16.0–23.6) by the sixth visit. Their 
mean diastolic blood pressure was 
100.5 mmHg at the first visit and this 
was reduced by 10.4 mmHg (95% CI: 
8.2–12.7) by the sixth visit. 
Costs
Table 2 shows the total costs of the 
intervention by input category and in-
tervention component. The awareness 
and screening component of the inter-
vention accounted for 38% (US$ 70 071) 
of the total cost of US$ 185 861, access 
to treatment for 44% (US$ 81 337) and 
retention in care for 19% (US$ 34 453). 
Personnel was the highest input cost at 
53% (US$ 99 119) of the total cost.
Table 3 summarizes the unit costs 
per patient with blood pressure con-
trolled for the three components of the 
intervention. The unit cost per person 
reached via screening and awareness was 
US$ 17. For access to treatment, the cost 
was estimated at US$ 123 per person 
seeking treatment. It cost US$ 194 per 
person to retain a patient in care. The 
overall cost of getting a person screened, 
treated, retained in care and to have 
their blood pressure under control was 
US$ 3205.
Discussion
In summary, the intervention reached 
60% of the target population, provided 
access to treatment to 68% of eligible 
patients with hypertension, retained 
27% in care and achieved blood pressure 
control among 33% of patients retained 
in care.
These results show that, despite the 
intervention, the so-called rule of halves 
– “half the hypertensive population is 
Table 1. Results of process evaluation of the community-based intervention for hypertension management in Kenya, 2012–2013
Intervention component by 
input category
Inputs Activities Outputs
Awareness and screening
Community gatherings 
(baraazas)
Banners, public address system, 
facilitators (community leaders, expert 
patients)
7 baraazas held Estimated between 50 and 
80 people attended each 
meeting
Religious services Facilitators (community health 
workers, religious leaders)
21 religious meetings held Estimated between 30 and 
50 people attended
Radio jingle Jingle content developer, local radio 
station (Koch FM)
1 jingle lasting 50 seconds aired 3 
times daily for 3 weeks
Koch FM radio listener 
numbers estimated at 
250 000 people
Community health workers Facilitators (medical/research officers), 
training facilities, allowances
1 training and 1 refresher training 
held
50 community health 
workers traineda
Door-to-door screening Community health worker allowances, 
screening equipment and materials
39 community health workers 
conducted door-to-door screenings
4049 people screened
Referral Free vouchers, confirmation of blood 
pressure by supervisor
39 community health workers 
conducted referrals
976 people referred
Treatment
Clinic staff Facilitators (medical/research officers), 
training facilities, allowances
1 training and 1 refresher training 
held
2 nurses, 2 clinical officers 
and 1 medical records clerk 
trained
Standard treatment guidelines Meetings and review by stakeholders 1 main meeting held with 
stakeholder. Guideline reviewed 
mostly by email correspondence
1 guideline document 
published
Upgrading and equipping of 
clinics
Construction of consultation area, 
equipment
2 clinics upgraded. Concrete floor 
constructed and tent erected in 1 
clinic. Both clinics received 2 sets 
of screening equipment and light 
furniture for consulting areas
2 clinics upgraded
Management of referred 
patients at clinics
Clinic staff allowances, utilities and 
supplies (including medication)
Clinics held twice a week for 17 
months
845 people attended clinic 
first time, of whom 660 were 
eligible for recruitment into 
care
Retention in care
Follow-up of defaulters Community health workers’ 
allowances (including incentives) and 
resources
188 defaulters followed up and 
interviewed by community health 
workers
46 defaulters returned to 
clinic after follow-up
SMS reminders Bulk SMS application 4519 SMS reminders sent 660 patients received SMS 
reminders
Support groups Community health workers, 
facilitators, incentives
7 support groups formed and 28 
support groups held
371 people attended 
support groups
SMS: short message service.
a  Although 50 community health workers were trained, not all were deployed to conduct screening. Some dropped out of the study to pursue other interests.
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undetected, half of those detected are 
untreated, and in half of those treated 
hypertension is not controlled”20 – ap-
plied in our setting. Studies in develop-
ing countries have shown that the levels 
of awareness, treatment and control of 
hypertension are still quite low, with 
control rates ranging from 4% to 47% 
among patients aged 35–49 years.21 
Even worldwide, only 13% of people 
with hypertension have adequate blood 
pressure control.22 Our study showed 
that with a comprehensive community-
based intervention it is possible to 
achieve awareness and initial treatment 
rates above 50%. Achieving awareness 
and access to treatment levels that are 
comparable to high-income countries 
is commendable, especially in unstable 
populations such as those in slum areas, 
where annual migration rates alone 
could reach 30%.23 However, retention 
in care and blood pressure control rates 
in our population remains suboptimal 
despite the intervention components 
designed to address them.
We also found that our financial in-
centives were not strong enough to keep 
the majority of patients retained in care. 
We believe that this finding is specific to 
our setting: over 90% of slum residents 
in Kenya make out-of-pocket payments 
for health24 and more than 50% report 
being food insecure.25 Moreover, many 
of those who defaulted from the clinic 
cited cost as the main reason. In other 
words, although treatment costs were 
subsidized, it was still a barrier to care. 
Cost is an issue in other settings too. A 
study in 36 mostly low- and middle-
income countries found that 1 month 
of daily treatment with one hypertensive 
drug cost on average 1.8 days’ wages.26 
The World Health Organization has 
set a global target of a 25% reduction 
in the prevalence of hypertension by 
2025.27 If this target is to be achieved, 
then mechanisms need to be found to 
make drugs more affordable, as has been 
achieved with tuberculosis treatment 
and antiretroviral therapy (ART) to 
supress human immunodeficiency virus 
(HIV) infection.
The cost of the entire intervention 
per person with blood pressure con-
trolled was US$ 3205. This compares 
favourably to other multifaceted public 
health interventions in Kenya. For 
example, the implementation of the 
option B+ approach, in which HIV-
positive pregnant women are started 
immediately on ART and continued 
for life – a comparable intervention 
as it includes screening, diagnosis and 
chronic treatment – was recently es-
timated to be US$ 6015 per infection 
averted.28 However, when we place the 
cost of each component of the hyper-
tension intervention in the context of 
other public health interventions for 
cardiovascular disease prevention we 
find that our costs are high. For example, 
a recent systematic review found that 
the costs of using general medical prac-
titioners in community hypertension 
programmes ranged from only US$ 0.81 
to US$ 8.67 per patient per year, versus 
our unit cost of US$ 123 per person 
seeking treatment.29 Furthermore, the 
per capita cost of the intervention was 
almost three times higher than the gross 
domestic product per capita of Kenya in 
2014 (US$ 1290).30 Yet compared with 
the treatment costs of other chronic 
diseases our costs are favourable. For 
example, from a provider perspective 
it costs US$ 273 and US$ 258 to treat 
drug-susceptible tuberculosis in lower 
middle-income and low-income coun-
tries, respectively.31 The median cost of 
antiretroviral therapy per patient per 
year is estimated to range from US$ 682 
to US$ 1089 in low-income countries 
and from US$ 156 to US$ 3904 in lower 
middle-income countries.32
The study has several limitations. 
First, due to budgetary limitations we 
were unable to collect all the data to 
compute the cost–effectiveness of our 
intervention, as originally intended in 
our study protocol for a quasi-experi-
mental community-based trial.13 This 
meant that we did not obtain fasting 
blood glucose levels for all study par-
ticipants to determine their 10-year 
cardiovascular diseases risk.14 Second, 
our study was conducted in a slum set-
ting, which limits the generalizability 
Fig. 1. Outcome and impact indicators for each stage in the cascade of hypertension 
diagnosis and management in the community-based intervention in Kenya, 
2012–2013
6780 eligible people aged > 35 years 
resident in area
660 patients recruited into treatment
(68% of 976 patients referred)
178 patients retained in care
(27% of 660 patients recruited into treatment)
4049 people screened and aware of 
hypertension risk
(60% of 6780 eligible people)
976 patients diagnosed with high blood 
pressure and referred: 618 newly diagnosed
(24% of 4049 people screened)
58 patients had blood pressure 
controlled by sixth visit
(33% of 178 patients retained in care; 9% of 
660 patients recruited into treatment)
2731 (40%) eligible people not screened:
• 164 refused to participate
• 1161 resident in slum; not reached
• 281 no longer resident in slum
• 26 dead
• 68  other reasons
• 1031 not included in study; traced at a later 
timepoint and given complimentary 
blood pressure check
316 (32%) referred people not recruited to treatment:
• 185 had normal blood pressure on rechecking
• 61 never attended clinic and gave reasons: 
17 lack of time, 14 cost of treatment, 9 forgot clinic 
appointment, 8 blood pressure did not improve, 
2 unaware of need to go, 11 other.
• 70 never attended clinic and reasons unknown 
(did not answer interview)
482 (73%) patients recruited to treatment not 
retained in care:
• 127 interviewed and gave reasons for drop-out:
45 cost of treatment, 26 lack of time, 22 forgot clinic 
appointment, 7 blood pressure did not improve, 
3 unaware of need to return, 24 other.
• 355 reasons for drop-out unknown 
(could not be interviewed)
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of our findings to other settings. None-
theless, as slums are said to constitute 
up to 60% of urban areas in low- and 
middle-income countries33 we believe 
our findings will be useful to urban 
health practitioners in other settings.
In conclusion, the intervention 
achieved reasonable success in terms 
of raising awareness and hyperten-
sion treatment levels in a challenging 
resource-constrained setting at a cost 
that in principle would be regarded 
Table 2. Total costs by input category and component of the 18-month community-based intervention for hypertension management 
in Kenya, 2012–2013
Input category Cost, US$
Awareness and 
screening
Treatment Retention in care All components (%)a
Personnel
CHWs facilitation fee (support groups) – – 329 329
Programme management 9 146 32 926 21 951 64 022
Field supervisor 3 747 3 747 3 747 11 241
Field team leaders 7 169 6 452 418 14 040
Clinical staff for cardiovascular diseases’ 
clinics
– 9 487 – 9 487
Total – – – 99 119 (53)
Commodities and supplies
Medical consumables 2 042 1 602 – 3 645
Non-medical supplies 3 642 6 590 – 10 231
Medicationsb 0 0 0 0
Total – – – 13 876 (8)
Training
Training sessions 4 498 1 519 748 6 765 (4)
Capital cost
Clinic upgrading – 1 190 – 1 190
Equipment 19 126 1 460 – 20 586
Furniture – 593 – 593
Total – – – 22 369 (12)
Building operating and maintenance
Repairs – 12 – 12
Field communication 302 272 18 591
Field security 590 – – 590
Cleaning – 104 – 104
Building rentc – 141 – 141
Total – – – 1 437 (1)
Transport
Transport for supervision visits 889 1 671 108 2 668 (1)
Intervention activities
CHWs for screening and referral 7 249 – – 7 249
CHWs for retention in care – – 935 935
First free treatment voucher – 1 165 – 1 165
Community gatherings (baraazas) 589 – – 589
Religious services 271 – – 271
Radio jingle 124 – – 124
Running of support groups – – 376 376
Training the trainers sessions – – 515 515
SMS reminders – – 53 53
Total – – – 11 275 (6)
Indirect expenses
Programme overheads (estimated at 18%) 10 689 12 407 5 256 28 352 (15)
All categories 70 071 81 337 34 453 185 861 (100)
CHWs: community health workers; SMS: short message service; US$: United States dollars.
a  Total cost of input category as a percentage of total intervention cost (US$ 185 861).
b  Drug costs were paid by patients.
c  Donated; value was estimated and included utilities (electricity, water, medical waste disposal etc.).
Notes: The average conversion rate during 2013 was 85 Kenyan shillings to US$ 1. Dashes indicate data not applicable.
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as affordable when compared with 
public health inter ventions such 
as ART. We recommend, however, 
that further research be conducted 
to address low levels of retention in 
care and of blood pressure control in 
such settings. In terms of scalability 
and sustainability, we believe that the 
strength of the intervention is that it 
simplifies the process of identifying 
persons with high blood pressure at 
community level and linking them 
into care. This characteristic has the 
potential to make it applicable to oth-
er contexts. Indeed, certain elements 
of the intervention have been imple-
mented successfully in other contexts. 
For example, an observational study 
in Bangladesh, Guatemala, Mexico 
and South Africa demonstrated that 
community health workers could do 
community-based screenings to pre-
dict cardiovascular disease risk as ef-
fectively as physicians or nurses.34 The 
clinics that we set up as part of this 
study were handed over to the local 
government in Kenya and continue to 
be operational in 2016. ■
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صخلم
اينيك في ةيرقفلا ةيضرلحا ءايحلأا دحأ في مدلا طغض عافترلا ةيعمتجلما تلاخدتلا ذيفنت نع ةتجانلا فيلاكتلاو تلاصحلما
 ذيفنت نع ةتجانلا فيلاكتلاو لئاصلحاو تايلمعلا فصو ضرغلا
 طاسوأ  في  مدلا  طغض  عافترلا  تانوكلما  ددعتم  يعمتمج  لخدت
 ةيضرلحا ءايحلأا دحأ في اًماع 35 نع مهرماعأ ديزت نيذلا ينغلابلا
.اينيك ،بيويرن في ةيربكلا ةيرقفلا
 2013 ماع لىإ 2012 ماع نم ةترفلا في ماقلما لخدتلا ناك ةقيرطلا
 لبس  ينستحو  ؛ةيعوتلا  ىوتسم  ةدايز  :تانوكم  ةعبرأ  لىع  ًمائاق
 طغض  عافترلا  ةدحولما  ةيريسرلا  ةلجاعلماو  ؛صحفلا  لىإ  عوضلخا
 فصوب انمق .ليوطلا ىدلما لىع ةياعرلا يقلت في رارمتسلااو ؛مدلا
 لئاصلحا ريدقتو لخدتلا ةطشنأ نم طاشن لكل جتاونلاو تلاخدلما
 ةددعتم رداصم مادختساب كلذو لخدتلا يرثأتو نوكم لكل ةتجانلا
 انمق  ماك  .ةيرادلإا  حوسلماو  تلاجسلا  كلذ  في  ماب  ،تانايبلا  نم
 جنه  عابتاب  كلذو  ،ذيفنتلا  ةيلمعب  ةطبترلما  فيلاكتلا  ريدقتب  اًضيأ
.ايندلا تايوتسلما لىإ ايلعلا تايوتسلما نم فيلاكتلا باسح
 ينفدهتسلما  ناكسلا  نم  % 60  لخدتلا  ةبسن  تغلب  جئاتنلا
 اًيكيرمأ  اًرلاود  17  ةفلكتب  ،)صاخشلأا  نم  6780/4049(
 لوصلحا ةيناكمإ يرفوتو ،صحفلل عضخ يذلا دحاولا صخشلل
 ينلاحلما  صاخشلأا  نم  )976/660(  68%  ةبسنب  جلاعلا  لىع
 نياعي يذلا دحاولا صخشلل اًيكيرمأ اًرلاود 123 ةفلكتب جلاعلل
 نم .ةدايعلا  في جلاعلا  يقتل  اوبهذ نيذلاو مدلا  طغض عافترا  نم
 مهددع  غلابلاو  ةدايعلا  لىإ  اوضرح  نيذلا  صاخشلأا  لياجمإ  ينب
 ،ةياعرلا يقلت في نورمتسم مهنم )178( 27% ناك ،اًصخش 660
 يقلت  في رمتسم صخش لكل اًيكيرمأ  اًرلاود 194  اهردق ةفلكتب
 مهنم )178/58( % 33 عاطتسا ،ضىرلما ءلاؤه ينب نمو ؛ةياعرلا
 صالخا لخدتلل ةيلاجملإا ةفلكتلا تغلبو .مدلا طغض لىع ةرطيسلا
.ةيكيرمأ تارلاود 3205 طوبضم مد طغضب عتمتي ضيرم لكب
 طغض  عافترا  ةروطخب  ةيعوتلا  قيقتح  نكملما  نم  ناك  جاتنتسلاا
 ةدوجولما  تايناكملإا  كلتل  ةلثمالما  جلاعلا  تايوتسم  ذيفنتو  مدلا
 .ةلدتعلما ذيفنتلا فيلاكت للاخ نم عفترلما لخدلا تاذ نكاملأا في
 تناك مدلا طغض لىع ةرطيسلاو ةياعرلا يقلت في رارمتسلاا نأ لاإ
 ةبسنلابف .يرقفلا يضرلحا يلحا اذه في اًيدتح لثتم يتلا  روملأا نم
 روملأا يه نايسنلا وأ تقولا قيض وأ فيلاكتلا تناك ،ضىرملل
.ةياعرلا يقلت في رارمتسلاا وحن تابقع لثتم يتلا
摘要
对肯尼亚城市贫民窟高血压疾病的基于社区干预的结果与成本
目标 旨在对一项基于社区的多组分干预的过程、结果
以及成本进行描述，该干预针对居住在肯尼亚内罗毕
一个大型贫民窟的 35 岁以上成年人患有的高血压疾
病开展。
方法 2012-2013 进行的干预基于 4 个不同组分 ： 增强意
识、提升筛查普及度、标准化高血压临床管理、以及
实现长期留院护理。 通过使用多来源数据，包括行政
记录和调查，我们描述了每项干预活动的输入和输出，
并且预测了每个组份的结果以及干预影响。我们还通
过使用自上而下的成本计算方法预测了执行相关成本。
结 果 该 干 预 范 围 涵 盖 了 60% 的 目 标 人 群
（4049/6780 人），平均筛查成本为每人 17 美元 (US$)，
Table 3. Summary of costs per unit of outcome at each stage of the community-based 
intervention for hypertension management in Kenya, 2012–2013
Intervention component Cost, US$ No. of people 
reached
Cost per person 
reached, US$
Awareness and screening 70 071 4 049 17
Treatment 81 337 660 123
Retention in care 34 453 178 194
Blood pressure control 185 861 58 3 205
US$: United States dollars.
Note: The average conversion rate during 2013 was 85 Kenyan shillings to US$ 1.
Bull World Health Organ 2016;94:501–509| doi: http://dx.doi.org/10.2471/BLT.15.156513508
Research
Community-based hypertension intervention in Kenya Samuel Oji Oti et al.
并且为 68% (660/976) 的参与人员提供了治疗，成本
为每位就诊的高血压患者 123 美元 (US$)。在就诊
的 660 人中，27% (178) 人留作住院护理，平均成本为
每人 194 美元 (US$) ；而上述患者中，33% (58/178) 患
者的血压得以控制。总体干预成本为每位血压得以控
制的高血压患者 3205 美元 (US$)。
结论 有了适当的干预成本，实现与高收入环境可比拟
的高血压防治意识以及治疗水平是可行的。 然而，在
贫民窟环境中，留院护理以及血压控制均提出很大挑
战。 对于患者来说，成本以及时间不足或者健忘都是
阻碍留院护理的障碍。
Résumé
Résultats et coûts de la mise en œuvre d’une intervention communautaire contre l’hypertension dans un bidonville urbain du Kenya
Objectif Décrire les processus, les résultats et les coûts de la mise en 
œuvre d’une intervention communautaire à composantes multiples 
contre l’hypertension auprès d’adultes de 35 ans et plus, dans un grand 
bidonville de Nairobi, au Kenya.
Méthodes Cette intervention, menée en 2012–2013, s’est articulée 
autour de quatre composantes: sensibilisation, amélioration de l’accès 
au dépistage, prise en charge clinique standardisée de l’hypertension; et 
rétention dans les soins sur le long terme. À partir de plusieurs sources de 
données, notamment des registres administratifs et des enquêtes, nous 
avons décrit les intrants et extrants de chaque activité constitutive de 
cette intervention et avons évalué les résultats de chaque composante 
ainsi que l’impact général de l’intervention. Nous avons également 
estimé les coûts associés à la mise en œuvre, en utilisant une approche 
de chiffrage descendante.
Résultats Cette intervention a touché 60% de la population ciblée 
(4 049/6 780 personnes), pour un coût de 17 dollars des États-Unis ($US) 
par personne dépistée, et a permis le traitement de 68% (660/976) des 
personnes orientées vers une clinique, pour un coût de 123 $US par 
personne hypertendue s’étant rendue à l’une des cliniques. Sur les 660 
personnes s’étant rendues à une clinique, 27% (178) ont été maintenues 
dans le continuum de soins, pour un coût de 194 $US par personne, 
et parmi ces patients, 33% (58/178) ont réussi à réguler leur pression 
artérielle. Le coût total de l’intervention par patient ayant réussi à réguler 
sa pression artérielle a été estimé à 3 205 $US.
Conclusion Avec des coûts de mise en œuvre modérés, il a été possible 
d’atteindre des niveaux de sensibilisation et de traitement comparables 
à ceux obtenus dans les pays à revenu élevé. Cependant, la rétention 
dans le continuum de soins et la régulation de la pression artérielle 
ont constitué de réels défis dans le contexte de ce bidonville. Pour 
les patients, les coûts, le manque de temps et l’oubli des rendez-vous 
médicaux ont été des freins pour poursuivre le continuum de soins.
Резюме
Результаты проведения на уровне общин вмешательства, нацеленного на борьбу с гипертонией, в 
городских трущобах Кении и затраты, связанные с ним
Цель Описать ход и результаты проведения комплексного 
общественного вмешательства, нацеленного на борьбу с 
гипертонией среди взрослого населения в возрасте старше 
35 лет в крупных трущобах г. Найроби, Кения, и затраты, связанные 
с ним.
Методы Вмешательство, проводимое в 2012–2013 гг. , 
базировалось на четырех составляющих: просветительской 
работе, повышении доступности скринингового обследования, 
стандартизированном клиническом лечении гипертонии и 
долгосрочном удержании пациентов в сфере оказания помощи. 
С помощью многочисленных источников данных, в том числе 
административных записей и опросов, авторы статьи описали 
затраченные ресурсы для каждого мероприятия вмешательства и 
его итоги, а также определили результаты каждой составляющей 
и эффект вмешательства. Также с помощью нисходящего анализа 
были определены затраты, связанные с вмешательством.
Результаты Охват вмешательства составил 60% целевого 
населения (4049 из 6780 человек), причем на каждого человека, 
прошедшего процедуру скринингового обследования, было 
затрачено 17 долларов США. Доступ к лечению получили 
68% (660 из 976) человек, которым оно было назначено, и затраты 
на каждого больного гипертонией, посетившего поликлинику, 
составили 123 доллара США. Из 660 человек, посетивших 
поликлинику, 27% (178) оставались в сфере оказания помощи, и 
затраты на каждого такого пациента составили 194 доллара США, 
из них у 33% (58 из 178) удалось контролировать уровень 
кровяного давления. Суммарные затраты на вмешательство для 
каждого пациента, чей уровень кровяного давления удалось 
контролировать, составили 3205 долларов США.
Вывод Умеренные затраты на проведение вмешательства 
позволили достичь уровней осведомленности о гипертонии и 
ее лечения, сопоставимых с уровнями, которые были достигнуты 
в регионах с высоким уровнем доходов. Однако удержание 
пациентов в сфере оказания помощи и контроль кровяного 
давления оказались затруднительными в условиях трущоб. Для 
пациентов препятствием к удержанию в сфере оказания помощи 
стала стоимость, нехватка времени или забывчивость.
Resumen
Resultados y costes de la implementación de una intervención basada en la comunidad para la hipertensión en un barrio pobre 
urbano de Kenya
Objetivo Describir los procesos, resultados y costes de la implementación 
de una intervención de varios componentes basada en la comunidad 
para la hipertensión en adultos de > 35 años en un gran barrio pobre 
de Nairobi, Kenya.
Métodos La intervención realizada en 2012-2013 se basaba en cuatro 
elementos: toma de conciencia; acceso mejorado a revisiones; gestión 
clínica de la hipertensión estandarizada; y recepción de atención a largo 
plazo. Utilizando numerosas fuentes de datos, incluidos expedientes 
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administrativos y encuestas, se describieron las contribuciones y el 
rendimiento de cada actividad de intervención y se calcularon los 
resultados de todos los componentes, así como el impacto de la 
intervención. También se calcularon los costes relacionados con la 
implementación utilizando un enfoque de gastos descendente.
Resultados La intervención llegó al 60% de la población objetivo 
(4 049/6 780 personas), con un coste de 17 dólares estadounidenses 
(USD) por persona examinada y un acceso al tratamiento del 68% 
(660/976) de las personas, con un coste de 123 USD por persona con 
hipertensión que acudió a la clínica. De las 660 que acudieron a la clínica, 
el 27% (178) recibieron atención, con un coste de 194 USD por persona 
atendida; y de dichos pacientes, el 33% (58/178) lograron controlar la 
tensión arterial. El coste total de la intervención por paciente con tensión 
arterial controlada fue de 3 205 USD. 
Conclusión Con costes moderados de implementación, fue posible 
lograr una toma de conciencia sobre la hipertensión y niveles de 
tratamiento comparables con aquellos de lugares con ingresos altos. 
No obstante, la recepción de atención y el control de la tensión arterial 
fueron muy complicados en este barrio pobre. Para los pacientes, el 
coste y la falta de tiempo o el olvido fueron obstáculos para recibir 
atención médica.
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